5N Plus Inc.
5N Plus Inc. (FPLSF) Financial Performance & Income Statement Overview
Analyze 5N Plus Inc. (FPLSF) financial statements (income, balance sheet, and cash flow) across both yearly and quarterly periods.
5N Plus Inc. (FPLSF) Income Statement & Financial Overview
Analyze 5N Plus Inc.’s FPLSF earnings with segmented quarterly and yearly financial statement figures.
| Metric | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 |
|---|---|---|---|---|
| Revenue | $88.89M | $70.85M | $78.83M | $74.58M |
| Cost of Revenue | $61.89M | $51.10M | $57.90M | $54.38M |
| Gross Profit | $27.00M | $19.75M | $20.92M | $20.20M |
| Gross Profit Ratio | $0.30 | $0.28 | $0.27 | $0.27 |
| R&D Expenses | $1.11M | $0.00 | $0.00 | $1.21M |
| SG&A Expenses | $9.95M | $9.86M | $8.13M | $8.70M |
| Operating Expenses | $11.88M | $13.60M | $11.43M | $11.05M |
| Total Costs & Expenses | $73.78M | $64.70M | $69.33M | $65.43M |
| Interest Income | $0.00 | $0.00 | $0.00 | $272000.00 |
| Interest Expense | $2.72M | $2.45M | $2.64M | $2.15M |
| Depreciation & Amortization | $4.45M | $4.43M | $4.49M | $4.11M |
| EBITDA | $20.28M | $10.30M | $14.43M | $13.53M |
| EBITDA Ratio | $0.23 | $0.15 | $0.18 | $0.18 |
| Operating Income | $15.11M | $6.15M | $9.49M | $9.15M |
| Operating Income Ratio | $0.17 | $0.09 | $0.12 | $0.12 |
| Other Income/Expenses (Net) | -$2.003M | -$2.73M | -$2.19M | -$1.88M |
| Income Before Tax | $13.11M | $3.42M | $7.30M | $7.27M |
| Income Before Tax Ratio | $0.15 | $0.05 | $0.09 | $0.10 |
| Income Tax Expense | $3.54M | $2.42M | $931000.00 | $2.48M |
| Net Income | $9.57M | $1.006M | $6.37M | $4.79M |
| Net Income Ratio | $0.11 | $0.01 | $0.08 | $0.06 |
| EPS | $0.11 | $0.01 | $0.07 | $0.05 |
| Diluted EPS | $0.11 | $0.01 | $0.07 | $0.05 |
| Weighted Avg Shares Outstanding | $89.04M | $88.95M | $88.95M | $95.78M |
| Weighted Avg Shares Outstanding (Diluted) | $89.84M | $89.75M | $89.75M | $89.60M |
The company's financials show resilient growth, with revenue advancing from $74.58M in Q2 2024 to $88.89M in Q1 2025. Gross profit remained healthy with margins at 30% in Q1 2025 compared to 27% in Q2 2024. Operating income hit $15.11M last quarter, sustaining a consistent 17% margin. Changes in R&D and SG&A spending did not hinder EBITDA, which stood at $20.28M. Net income rose to $9.57M, while earnings per share reached $0.11. Strong cost management and operational efficiency kept profitability intact, underlining the company's stable and competitive market performance.
Unlock 25+ Years of Financial Data
Get access to extended historical data, advanced metrics, and more with our premium plan